Article
Spinal muscular atrophy: from tissue specificity to therapeutic strategies
5 Jan 2015
Abstract excerpt
Spinal muscular atrophy (SMA) is the most frequent genetic cause of death in infants and toddlers. All cases of spinal muscular atrophy result from reductions in levels of the survival motor neuron (SMN) protein, and so SMN upregulation is a focus of many preclinical and clinical studies. We examine four issues that may be important in planning for therapeutic success. First, neuromuscular phenotypes in the SMNΔ7...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
